Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Intelgenx Technologies Corp IGXT


Primary Symbol: T.IGX

Healthcare
IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company provides single-site, end-to-end contract development and manufacturing services of oral thin film and transdermal drug products for the pharmaceutical and animal health markets, spanning the entire drug development and commercial product cycle. The Company’s film technologies, including VersaFilm, DisinteQ... see more

Recent & Breaking News (TSX:IGX)

IntelGenx Completes CDN$6.8 Million Convertible Debenture Offering

Marketwired July 12, 2017

IntelGenx Files Final Short Form Prospectus In Connection With Offering of Convertible Unsecured Debentures

MarketWire Canada June 29, 2017

IntelGenx Receives USPTO Notice of Allowance for Oral Film Dosage Form Technology Patent

MarketWire Canada June 27, 2017

IntelGenx Announces Issuance of US Patent for Topical Oral Film Technology

Marketwired June 8, 2017

IntelGenx Reports First Quarter 2017 Financial Results

MarketWire Canada May 11, 2017

Investor Network: Intelgenx Technologies Corp. to Host Earnings Call

Accesswire May 11, 2017

IntelGenx to Report First Quarter 2017 Financial Results on May 11, 2017 - Conference Call to Follow

Marketwired May 4, 2017

IntelGenx and RedHill Biopharma Announce Marketing Approval of RIZAPORT(R) for Migraines in Luxembourg

MarketWire Canada April 13, 2017

RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT® for Migraines in Luxembourg

GlobeNewswire April 13, 2017

IntelGenx Files Preliminary Short Form Prospectus in Connection With a Proposed Offering of Convertible Unsecured Debentures

Marketwired April 5, 2017

IntelGenx Presents at the 13th International Conference on Alzheimer's and Parkinson's Diseases

MarketWire Canada April 4, 2017

IntelGenx and Tetra Bio-Pharma Announce the Signing of a Definitive Agreement for the Development and Commercialization of a Dronabinol XL Tablet

MarketWire Canada April 3, 2017

IntelGenx Reports Fourth Quarter and Full-Year 2016 Financial Results

MarketWire Canada March 28, 2017

Oral Film Exclusivity Granted to IntelGenx' VersaFilm(TM) for Tadalafil Erectile Dysfunction Dosing Patent

MarketWire Canada March 28, 2017

IntelGenx to Report Fourth Quarter and Full Year 2016 Financial Results on March 28, 2017 - Conference Call to Follow

Marketwired March 21, 2017

IntelGenx Engages Kilmer Lucas for Cross-Border Investor Relations

MarketWire Canada March 13, 2017

IntelGenx and Tetra Bio-Pharma Announce the Signing of a Term Sheet for the Development and Commercialization of a Dronabinol XL Tablet

MarketWire Canada February 9, 2017

IntelGenx Presentation Now Available for On-Demand Viewing

PR Newswire February 6, 2017

Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present February 2nd

PR Newswire January 30, 2017

IntelGenx to Webcast, Live, at VirtualInvestorConferences.com February 2

PR Newswire January 30, 2017